Testosterone Replacement Therapy and Cardiovascular Risk: A Review

Recent reports in the scientific and lay press have suggested that testosterone (T) replacement therapy (TRT) is likely to increase cardiovascular (CV) risk. In a final report released in 2015, the Food and Drug Administration (FDA) cautioned that prescribing T products is approved only for men who...

Descripción completa

Detalles Bibliográficos
Autores principales: Corona G, Giovanni, Rastrelli, Giulia, Maseroli, Elisa, Sforza, Alessandra, Maggi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Sexual Medicine and Andrology 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709429/
https://www.ncbi.nlm.nih.gov/pubmed/26770933
http://dx.doi.org/10.5534/wjmh.2015.33.3.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709429/
https://www.ncbi.nlm.nih.gov/pubmed/26770933
http://dx.doi.org/10.5534/wjmh.2015.33.3.130

Ejemplares similares